144 related articles for article (PubMed ID: 30258129)
1. Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome.
Kongtim P; Parmar S; Milton DR; Perez JMR; Rondon G; Chen J; Chilkulwar AR; Al-Atrash G; Alousi A; Andersson BS; Im JS; Hosing CM; Bashir Q; Khouri I; Kebriaei P; Oran B; Popat U; Champlin R; Ciurea SO
Bone Marrow Transplant; 2019 Jun; 54(6):839-848. PubMed ID: 30258129
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.
Platzbecker U; Schetelig J; Finke J; Trenschel R; Scott BL; Kobbe G; Schaefer-Eckart K; Bornhäuser M; Itzykson R; Germing U; Beelen D; Ehninger G; Fenaux P; Deeg HJ; Adès L; ; ; ;
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1415-21. PubMed ID: 22579634
[TBL] [Abstract][Full Text] [Related]
3. Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pasvolsky O; Saliba RM; Popat UR; Alousi A; Mehta R; Yeh J; Al-Atrash G; Adeel M; Ramdial J; Marin D; Rondon G; Kebriaei P; Champlin R; Daver N; Dinardo C; Short NJ; Shpall EJ; Oran B
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):e196-e204. PubMed ID: 38403505
[TBL] [Abstract][Full Text] [Related]
4. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
[TBL] [Abstract][Full Text] [Related]
5. Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care.
Tomlinson B; de Lima M; Cogle CR; Thompson MA; Grinblatt DL; Pollyea DA; Komrokji RS; Roboz GJ; Savona MR; Sekeres MA; Abedi M; Garcia-Manero G; Kurtin SE; Maciejewski JP; Patel JL; Revicki DA; George TI; Flick ED; Kiselev P; Louis CU; DeGutis IS; Nifenecker M; Erba HP; Steensma DP; Scott BL
Transplant Cell Ther; 2023 Jul; 29(7):460.e1-460.e9. PubMed ID: 37086851
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Pasquini MC; Zhang MJ; Medeiros BC; Armand P; Hu ZH; Nishihori T; Aljurf MD; Akpek G; Cahn JY; Cairo MS; Cerny J; Copelan EA; Deol A; Freytes CO; Gale RP; Ganguly S; George B; Gupta V; Hale GA; Kamble RT; Klumpp TR; Lazarus HM; Luger SM; Liesveld JL; Litzow MR; Marks DI; Martino R; Norkin M; Olsson RF; Oran B; Pawarode A; Pulsipher MA; Ramanathan M; Reshef R; Saad AA; Saber W; Savani BN; Schouten HC; Ringdén O; Tallman MS; Uy GL; Wood WA; Wirk B; Pérez WS; Batiwalla M; Weisdorf DJ
Biol Blood Marrow Transplant; 2016 Feb; 22(2):248-257. PubMed ID: 26327629
[TBL] [Abstract][Full Text] [Related]
7. Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.
Woo J; Deeg HJ; Storer B; Yeung C; Fang M; Mielcarek M; Scott BL
Biol Blood Marrow Transplant; 2017 Jan; 23(1):176-179. PubMed ID: 27789363
[TBL] [Abstract][Full Text] [Related]
8. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
Sung AD; Koll T; Gier SH; Racioppi A; White G; Lew M; Free M; Agarwal P; Bohannon LM; Johnson EJ; Selvan B; Babushok DV; Frey NV; Gill SI; Hexner EO; Martin M; Perl AE; Pratz KW; Luger SM; Chao NJ; Fisher AL; Stadtmauer EA; Porter DL; Loren AW; Bhatt VR; Gimotty PA; McCurdy SR
Transplant Cell Ther; 2024 Apr; 30(4):415.e1-415.e16. PubMed ID: 38242440
[TBL] [Abstract][Full Text] [Related]
9. Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome.
Nakamura R; Saber W; Martens MJ; Ramirez A; Scott B; Oran B; Leifer E; Tamari R; Mishra A; Maziarz RT; McGuirk J; Westervelt P; Vasu S; Patnaik M; Kamble R; Forman SJ; Sekeres MA; Appelbaum F; Mendizabal A; Logan B; Horowitz M; Cutler C
J Clin Oncol; 2021 Oct; 39(30):3328-3339. PubMed ID: 34106753
[TBL] [Abstract][Full Text] [Related]
10. Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.
Vaughn JE; Storer BE; Armand P; Raimondi R; Gibson C; Rambaldi A; Ciceri F; Oneto R; Bruno B; Martin PJ; Sandmaier BM; Storb R; Sorror ML
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1418-24. PubMed ID: 25862589
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation.
Yalniz FF; Greenbaum U; Pasvolsky O; Milton DR; Kanagal-Shamanna R; Ramdial J; Srour S; Mehta R; Alousi A; Popat UR; Nieto Y; Kebriaei P; Al-Atrash G; Oran B; Hosing C; Ahmed S; Champlin RE; Shpall EJ; Qazilbash MH; Bashir Q
Transplant Cell Ther; 2024 Feb; 30(2):205.e1-205.e12. PubMed ID: 37437764
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation (HCT) in MDS patients of older age.
Niederwieser C; Kröger N
Leuk Lymphoma; 2024 May; 65(5):570-584. PubMed ID: 38315612
[TBL] [Abstract][Full Text] [Related]
13. Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation.
Dong J; Buradagunta CS; Zhang T; Spellman S; Bolon YT; DeZern AE; Gadalla SM; Deeg HJ; Nazha A; Cutler C; Cheng C; Urrutia R; Auer P; Saber W
J Hematol Oncol; 2023 Mar; 16(1):21. PubMed ID: 36899395
[TBL] [Abstract][Full Text] [Related]
14. Cardio-oncology and transplantation for acute myeloid leukemia.
Singh J
Best Pract Res Clin Haematol; 2023 Jun; 36(2):101465. PubMed ID: 37353290
[TBL] [Abstract][Full Text] [Related]
15. Decision Analysis of Transplantation for Patients with Myelodysplasia: "Who Should We Transplant Today?".
Arslan S; Nakamura R
Curr Hematol Malig Rep; 2020 Aug; 15(4):305-315. PubMed ID: 32222884
[TBL] [Abstract][Full Text] [Related]
16. Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Salas MQ; Rodríguez-Lobato LG; Charry P; Suárez-Lledó M; Pedraza A; Solano MT; Arcarons J; Cid J; Lozano M; Rosiñol L; Esteve J; Carreras E; Fernández-Avilés F; Martínez C; Rovira M
Hematol Transfus Cell Ther; 2023 Oct; ():. PubMed ID: 37891074
[TBL] [Abstract][Full Text] [Related]
17. Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML.
Nawas MT; Kosuri S
Blood Adv; 2024 Feb; 8(3):553-561. PubMed ID: 38096805
[TBL] [Abstract][Full Text] [Related]
18. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
Muffly L; Pasquini MC; Martens M; Brazauskas R; Zhu X; Adekola K; Aljurf M; Ballen KK; Bajel A; Baron F; Battiwalla M; Beitinjaneh A; Cahn JY; Carabasi M; Chen YB; Chhabra S; Ciurea S; Copelan E; D'Souza A; Edwards J; Foran J; Freytes CO; Fung HC; Gale RP; Giralt S; Hashmi SK; Hildebrandt GC; Ho V; Jakubowski A; Lazarus H; Luskin MR; Martino R; Maziarz R; McCarthy P; Nishihori T; Olin R; Olsson RF; Pawarode A; Peres E; Rezvani AR; Rizzieri D; Savani BN; Schouten HC; Sabloff M; Seftel M; Seo S; Sorror ML; Szer J; Wirk BM; Wood WA; Artz A
Blood; 2017 Aug; 130(9):1156-1164. PubMed ID: 28674027
[TBL] [Abstract][Full Text] [Related]
19. Blood and marrow transplant clinical trials network state of the Science Symposium 2014.
Appelbaum FR; Anasetti C; Antin JH; Atkins H; Davies S; Devine S; Giralt S; Heslop H; Laport G; Lee SJ; Logan B; Pasquini M; Pulsipher M; Stadtmauer E; Wingard JR; Horowitz MM
Biol Blood Marrow Transplant; 2015 Feb; 21(2):202-24. PubMed ID: 25445636
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
